🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us on for our highly popular #FDLI Annual25 session that takes an in-depth look at the top cases shaping food and drug regulation. From key government enforcement actions to private litigation, we'll break down the cases making headlines. Register now fdli.org/annual25

Join us on May 28 at 2 PM ET as regulatory, academic, and legal experts analyze constitutional challenges to the #InflationReductionAct’s #DrugPriceNegotiation Program and reform under the April 15 executive order. Register now at s.tnycc.com/wlWCIx

Big news! FDLI has confirmed Dr. Martin A. Makary, Commissioner of Food and Drugs, FDA, as the keynote speaker for the 2025 FDLI Annual Conference. View the full agenda and register now at fdli.org/annual25

This Week at FDLI! Visit fdli.org/programs to register for this week's events

FDLI is excited to welcome Commissioner of Food and Drugs, Dr. Martin Makary, and Deputy General Counsel and Chief Counsel for Food, Research, and Drugs at HHS, Bob Foster, as the keynote speakers for our #FDLIAnnual25 Conference! View full agenda at fdli.org/annual25

Spotlight #FDLIAnnual25 session: Are your or your client’s products in America’s online shopping cart? Hear from our experts on how to ensure safety and regulatory compliance in the rapidly expanding online marketplace in light of evolving FDA regulations. fdli.org/annual25

The countdown is on—just one week until the #FDLIAnnual25! In these unprecedented times, FDLI remains your trusted guide, helping you make sense of complex regulatory landscapes and find the answers you need to move forward with confidence. Register now: fdli.org/annual25

Just confirmed! We're excited to announce that Grace Graham, FDA's Deputy Commissioner for Policy and Legislation, and International Affairs, will deliver a keynote address on Day 2 of the 2025 FDLI Annual Conference! View the full agenda and register now: fdli.org/annual25

⏳ Last Chance to Save! Registration rates for the FDLI Annual Conference go up tomorrow! Join leading professionals and regulators in food and drug law for essential insights and networking. Secure your spot today: fdli.org/annual25 #FDLIAnnual25

FDLI is accepting session proposals for the 2025 Enforcement, Litigation, and Compliance Conference—an essential conference for professionals in the drug, device, food, and tobacco industries. Submit your proposal by May 23: bit.ly/4iT89lc

#FDLIAnnual25 Speaker Spotlight: Abe Sutton, Director of the Center for Medicare and Medicaid Innovation and Deputy Administrator, CMS. View the full agenda and register at fdli.org/annual25

Time is running out to register for #FDLIAnnual25, the must-attend event for the food and drug law community. Whether you work in government, industry, private practice, or academia, join us to discuss the most pressing issues in FDA-regulated products. fdli.org/annual25

Hear directly from FDA Commissioner Dr. Martin A. Makary alongside FDLI President & CEO Christine M. Simmon in an engaging Fireside Chat at this week’s #FDLIAnnual25! If you haven't already, register now at fdli.org/annual25

We look forward to welcoming Robert F. Foster, Deputy General Counsel and Chief Counsel for Food, Research, and Drugs, HHS, for a fireside chat moderated by Perham Gorji on Day 1 of #FDLIAnnual25. If you haven't registered yet, go to fdli.org/annual25 to learn more.

The final countdown is on for the #FDLIAnnual25! We’re excited to welcome our food and drug law colleagues tomorrow at the Ronald Reagan Building in Washington, D.C. It’s not too late to join us — in-person or virtually! Register now at fdli.org/annual25.

FDA Commissioner Dr. Marty Makary gave the keynote address at today’s Food & Drug Law Institute’s 2025 Annual Conference discussing the childhood disease epidemic, vaping crisis, and leveraging AI in the medical review process space. FDLI

Panelists will offer insights into FDA’s evolving structure, implications of staff departures on medical product review and approval, potential disruptions to user fee negotiations, and tips on how to move forward during this period of transition. bit.ly/44AFfmw

I spoke on a panel FDLI with FDA Tobacco, Truth Initiative, and Juul Labs Inc. and we found common ground on taking massive efforts to rein in and regulate the illicit e-cigarette market Rutgers Institute for Nicotine & Tobacco Studies Rutgers SPH Rutgers Addiction Research Center

Always appreciate Skip Murray, DSP, TTS’s contribution to #nicotine conferences. Unfortunately, we so rarely hear from people who use nicotine in these types of conversations. Glad FDLI included her on the panel!

Thanks for the shoutout Sheppard Mullin! Check out their "Reflections on the FDLI 2025 Annual Conference – Differing Tones, Shared Goals" jdsupra.com/legalnews/refl…